Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nu-Med Plus Inc (NUMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6558
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nu-Med Plus Inc (Nu-Med Plus) is a medical device company. The company offers medical products that deliver therapeutic doses of nitric oxide gas to patients. It provides nitric oxide gas delivery system, portable nitric oxide delivery system and nitric oxide dilution system. Nu-Med Plus’ nitric oxide is used for malaria, congenital pulmonary hypoplasia and neonatal hypoxia therapy. The company’s nitric oxide gas delivery system offers an intra-breath concentration of therapeutic nitric oxide to medically supervised patients on ventilators. It has developed inhaled nitric oxide products for use in hospital settings and for long-term applications. The company operates its laboratory in Orem, the US. Nu-Med Plus is headquartered in Salt Lake City, Utah, the US.

Nu-Med Plus Inc (NUMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nu-Med Plus Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nu-Med Plus Raises US$0.12 Million In Venture Financing 10
Nu-Med Plus Raises US$0.09 Million In Venture Financing 11
Equity Offering 12
Nu-Med Plus Raises USD0.3 Million in Private Placement of Shares 12
Nu-Med Plus Inc – Key Competitors 13
Nu-Med Plus Inc – Key Employees 14
Nu-Med Plus Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Jun 26, 2018: Nu-Med Plus Selects s2s Public Relations firm as its Strategic Partner 16
Corporate Communications 17
Feb 13, 2018: Nu-Med Plus Names Keith L. Merrell as full-time Chief Financial Officer and Secretary/Treasurer 17
Legal and Regulatory 18
Jul 31, 2018: Nu-Med Plus Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval 18
Product News 19
Aug 16, 2018: Nu-Med optimistic about nitric oxide prospects after patent ruling 19
Jun 05, 2018: Nu-Med Plus applies for Innovative Patent on Reactive Tube Coating 20
Other Significant Developments 21
Oct 09, 2018: Nu-Med Plus announces strategic rebrand to focus on leading advancements in the nitric oxide delivery industry 21
Aug 14, 2018: Nu-Med Plus Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market 22
Jun 12, 2018: Nu-Med Plus engages Millennium Biosciences for Quality and Regulatory consulting services 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Nu-Med Plus Inc, Medical Equipment, Key Facts, 2017 2
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Deals By Market, 2012 to YTD 2018 8
Nu-Med Plus Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nu-Med Plus Raises US$0.12 Million In Venture Financing 10
Nu-Med Plus Raises US$0.09 Million In Venture Financing 11
Nu-Med Plus Raises USD0.3 Million in Private Placement of Shares 12
Nu-Med Plus Inc, Key Competitors 13
Nu-Med Plus Inc, Key Employees 14
Nu-Med Plus Inc, Other Locations 15

List of Figures
Nu-Med Plus Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nu-Med Plus Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nu-Med Plus Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nu-Med Plus Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nu-Med Plus Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arc Logistics Partners LP (ARCX):石油・ガス:M&Aディール及び事業提携情報
    Summary Arc Logistics Partners LP (Arc Logistics Partners) is an oil and gas company that provides energy logistics services. The company owns and operates terminaling, storage, rail, transloading, and pipeline assets. It transports various products including gasoline, distillates, fuels, aviation g …
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Global Bio-chem Technology Group Company Limited (809):企業の財務・戦略的SWOT分析
    Global Bio-chem Technology Group Company Limited (809) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Korea Electric Power Corp (015760):電力:M&Aディール及び事業提携情報
    Summary Korea Electric Power Corp (KEPCO) is an integrated electric utility. It generates, transmits, and distributes electricity. The company produces electricity using nuclear, thermal, renewable, and other sources. Through power purchase agreements with independent power producers, KEPCO procures …
  • PT Bumi Resources Tbk:企業のM&A・事業提携・投資動向
    PT Bumi Resources Tbk - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PT Bumi Resources Tbk Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • KDDI Corporation:戦略・SWOT・企業財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Perrigo Company plc:企業の戦略・SWOT・財務情報
    Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pengrowth Energy Corp (Pengrowth) is an oil and gas company that explores, acquires, develops and produces oil and natural gas reserves. The company's services include development of large accu …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • Copelouzos group-エネルギー分野:企業M&A・提携分析
    Summary Copelouzos group (Copelouzos) is an energy company that offers business development services. The company’s services include energy production and training, equipment supply, wastes management, natural gas, and concession and property services. It’s waste management services include residues …
  • Barratt Developments Plc:企業の戦略・SWOT・財務情報
    Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report Summary Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BTG Plc (BTG):医療機器:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • ZIOPHARM Oncology Inc (ZIOP):企業の財務・戦略的SWOT分析
    Summary Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy for cold tumors by turning them hot by activating an immune resp …
  • Athena Resources Ltd (AHN):企業の財務・戦略的SWOT分析
    Summary Athena Resources Ltd (Athena Resources) is a mining and mineral exploration company that explores nickel, iron, copper and other mineral properties in Australia. The company carries out acquisition of mineral projects with the potential to be developed into profitable mining operations. It t …
  • Hecla Mining Company
    Hecla Mining Company - Strategy, SWOT and Corporate Finance Report Summary Hecla Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SiteOne Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary SiteOne Therapeutics Inc (SiteOne) is a developer of novel therapeutics and diagnostics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates comprise selective inhibitors of a voltage-gated sodium ion channel, Na 1.7 which helps to generate and conduct pain …
  • Metinvest BV:企業の戦略・SWOT・財務情報
    Metinvest BV - Strategy, SWOT and Corporate Finance Report Summary Metinvest BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆